Glucose-induced norepinephrine levels and obesity resistance

Area of Science:

• Physiology
• Metabolic Research
• Obesity Research

Background:

• Diet-induced obesity (DIO) is a significant health concern.
• Understanding factors predicting obesity development is crucial.
• Sympathetic nervous system (SNS) activity plays a role in metabolic regulation.

Purpose of the Study:

• To investigate the role of glucose-stimulated sympathetic activation in differentiating rats that resist or develop DIO.
• To determine if pre-existing differences in sympathetic response predict obesity susceptibility.

Main Methods:

• Male Sprague-Dawley rats were given an intravenous glucose load.
• Plasma glucose, insulin, and norepinephrine (NE) levels were measured.
• Rats were subsequently fed a high-calorie diet (CM) for 14 weeks to assess DIO development.

Main Results:

• Rats that developed DIO showed significantly higher weight gain and retroperitoneal fat pad weights compared to diet-resistant (DR) rats.
• NE levels after glucose load were 54% lower in DR rats compared to DIO rats.
• A positive correlation was found between NE levels and subsequent weight gain on the CM diet.

Conclusions:

• Dampened sympathetic activation following a glucose load may predispose rats to DIO.
• Heightened end-organ responsiveness to NE could underlie this dampened sympathetic response in diet-resistant rats.
• Glucose-stimulated sympathetic response is a potential biomarker for predicting obesity susceptibility.